A China Drug Master File (DMF) requires submission in Chinese, including detailed sections on manufacturing processes, quality control, stability data, and safety information. It must adhere to the National Medical Products Administration (NMPA) guidelines, ensuring comprehensive documentation, electronic format compatibility, and confidentiality agreements for proprietary information.
